GlassScriptPhysician profile
Adam Mitchell Katz
NPI 1790772101
$5,872.85
in general payments reported to CMS, 2019-2025
39 companies · $406 in 2025
The $406 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,998 · 2020: $206 · 2021: $597 · 2022: $669 · 2023: $423 · 2024: $574 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,403.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,662.86 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $596.03 | 2019-2025 | Eylea, Eylea Hd |
| Novartis Pharmaceuticals Corporation | $259.52 | 2019-2023 | |
| Genentech USA, INC. | $214.07 | 2019-2023 | Vabysmo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $201.33 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $185.25 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $150.21 | 2024-2025 | Xdemvy |
| Abbvie INC. | $135.94 | 2022-2024 | |
| Alimera Sciences, INC. | $130.93 | 2024 | Iluvien, Yutiq |
| Innovation Technologies INC | $118.84 | 2025 | Irrisept |
| Horizon Therapeutics Plc | $107.11 | 2019-2023 | Tepezza |
| Apellis Pharmaceuticals, INC. | $96.38 | 2023-2024 | Syfovre |
| Omeros Corporation | $92.50 | 2019-2021 | |
| Topcon Healthcare, INC. | $85.93 | 2019 | |
| Djo, LLC | $68.84 | 2025 | Cmf |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.